Literature DB >> 16279766

Identification of novel and improved antimitotic agents derived from noscapine.

James T Anderson1, Anthony E Ting, Sherry Boozer, Kurt R Brunden, Chris Crumrine, Joel Danzig, Tom Dent, Laurel Faga, John J Harrington, William F Hodnick, Steven M Murphy, Gary Pawlowski, Robert Perry, Amy Raber, Stephen E Rundlett, Alain Stricker-Krongrad, Jianmin Wang, Youssef L Bennani.   

Abstract

Analogues of the natural product noscapine were synthesized and their potential as antitumor agents evaluated. The discovery of a novel regioselective O-demethylation facilitated the synthesis of the potent aniline 6, which arrests mammalian cells in the G2/M phase of the cell cycle at 0.1 microM and also affects tubulin polymerization. Aniline 6 is orally bioavailable and is 250-fold more potent than noscapine in reducing cell proliferation in rapidly dividing cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279766     DOI: 10.1021/jm050674q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.

Authors:  Mahavir Chougule; Apurva R Patel; Pratik Sachdeva; Tanise Jackson; Mandip Singh
Journal:  Lung Cancer       Date:  2010-07-31       Impact factor: 5.705

2.  Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.

Authors:  Maged Henary; Lakshminarayana Narayana; Shazia Ahad; Sushma R Gundala; Rao Mukkavilli; Vibhuti Sharma; Eric A Owens; Yogesh Yadav; Mulpuri Nagaraju; Donald Hamelberg; Vibha Tandon; Dulal Panda; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2014-08-11       Impact factor: 5.858

Review 3.  Peloruside, laulimalide, and noscapine interactions with beta-tubulin.

Authors:  Melissa M Gajewski; Laleh Alisaraie; Jack A Tuszynski
Journal:  Pharm Res       Date:  2012-06-26       Impact factor: 4.200

4.  Dialkylbiaryl Phosphines in Pd-Catalyzed Amination: A User's Guide.

Authors:  David S Surry; Stephen L Buchwald
Journal:  Chem Sci       Date:  2011       Impact factor: 9.825

5.  Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.

Authors:  Ram C Mishra; Sushma R Gundala; Prasanthi Karna; Manu Lopus; Kamlesh K Gupta; Mulpuri Nagaraju; Donald Hamelberg; Vibha Tandon; Dulal Panda; Michelle D Reid; Ritu Aneja
Journal:  Bioorg Med Chem Lett       Date:  2015-03-31       Impact factor: 2.823

6.  Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.

Authors:  Ram Chandra Mishra; Prasanthi Karna; Sushma Reddy Gundala; Vaishali Pannu; Richard A Stanton; Kamlesh Kumar Gupta; M Hope Robinson; Manu Lopus; Leslie Wilson; Maged Henary; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2011-04-08       Impact factor: 5.858

Review 7.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

Review 8.  Biaryl phosphane ligands in palladium-catalyzed amination.

Authors:  David S Surry; Stephen L Buchwald
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

9.  (3R*,5'S*)-6,7-Dimeth-oxy-3-(4'-meth-oxy-6'-methyl-5',6',7',8'-tetra-hydro-1,3-dioxolo[4,5-g]isoquinolin-5'-yl)isobenzofuran-1(3H)-one (racemic α-noscapine).

Authors:  Jan von Langermann; Heike Lorenz; Oliver Boehm; Anke Flemming; Arne Bernsdorf; Martin Köckerling; Dieter Schinzer; Andreas Seidel-Morgenstern
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-10

10.  Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.

Authors:  Tanise Jackson; Mahavir B Chougule; Nkechi Ichite; Ram R Patlolla; Mandip Singh
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.